Patents by Inventor Scott Michael Silbiger

Scott Michael Silbiger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATMENT USING IL-17E ANTAGONISTS
    Publication number: 20140037635
    Abstract: Novel IL-17 like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing IL-17 like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with IL-17 like polypeptides, agonists, or antagonists thereof.
    Type: Application
    Filed: June 26, 2013
    Publication date: February 6, 2014
    Applicant: Amgen Inc.
    Inventors: Eugene MEDLOCK, Gary S. ELLIOTT, Shuqian JING, Scott Michael SILBIGER, Hung Q. NGUYEN, Richard YEH
  • METHODS OF TREATMENT USING IL-17E ANTAGONISTS
    Publication number: 20100303820
    Abstract: Novel IL-17 like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing IL-17 like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with IL-17 like polypeptides, agonists, or antagonists thereof.
    Type: Application
    Filed: May 25, 2010
    Publication date: December 2, 2010
    Applicant: Amgen Inc.
    Inventors: Eugene Medlock, Richard Yeh, Scott Michael Silbiger, Gary S. Elliott, Hung Q. Nguyen, Shuqian Jing
  • TNF RECEPTOR-LIKE MOLECULES AND USES THEREOF
    Publication number: 20090325880
    Abstract: Novel MK61 polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing MK61 polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with MK61 polypeptides.
    Type: Application
    Filed: June 19, 2009
    Publication date: December 31, 2009
    Inventors: LARS EYDE THEILL, RICHARD YEH, SCOTT MICHAEL SILBIGER, GANG YU, GIORGIO SENALDI
  • IL-receptor like molecules and uses thereof
    Patent number: 7611857
    Abstract: The present invention provides for IL-17 receptor like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, agonists and antagonists (including selective binding agents), and methods for producing IL-17 receptor like polypeptides. Also provided for are methods for treatment, diagnosis, amelioration, or prevention of diseases with IL-17 receptor like polypeptides.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: November 3, 2009
    Assignee: Amgen Inc.
    Inventors: Eugene Medlock, Richard Yeh, Scott Michael Silbiger, Gary S. Elliott, Hung Q. Nquyen, Shuqian Jing
  • Antibody to TNF receptor-like molecules
    Patent number: 7569387
    Abstract: Novel MK61 polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing MK61 polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with MK61 polypeptides.
    Type: Grant
    Filed: May 17, 2006
    Date of Patent: August 4, 2009
    Assignee: Amgen Inc.
    Inventors: Lars Eyde Theill, Richard Yeh, Scott Michael Silbiger, Gang Yu, Giorgio Senaldi
  • Nucleic acids encoding MK61 receptors
    Patent number: 7153669
    Abstract: Novel MK61 polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing MK61 polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with MK61 polypeptides.
    Type: Grant
    Filed: September 5, 2001
    Date of Patent: December 26, 2006
    Assignee: Amgen Inc.
    Inventors: Lars Eyde Theill, Richard Yeh, Scott Michael Silbiger, Gang Yu, Giorgio Senaldi
  • IL-17 like molecules and uses thereoflike molecules and uses thereof
    Publication number: 20030124092
    Abstract: Novel IL-17 like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing IL-17 like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with IL-17 like polypeptides, agonists, or antagonists thereof.
    Type: Application
    Filed: December 21, 2001
    Publication date: July 3, 2003
    Inventors: Eugene Medlock, Richard Yeh, Scott Michael Silbiger, Gary S. Elliot, Hung Q. Nguyen, Shuqian Jing
  • TNF receptor-like molecules and uses thereof
    Publication number: 20020150977
    Abstract: Novel MK61 polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing MK61 polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with MK61 polypeptides.
    Type: Application
    Filed: September 5, 2001
    Publication date: October 17, 2002
    Inventors: Lars Eyde Theill, Richard Yeh, Scott Michael Silbiger, Gang Yu, Giorgio Senaldi